trial · primary record
SFL-0821 for injection
Facioscapulohumeral Muscular Dystrophy (FSHD)
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 90 |
| Primary completion | 2028-04 |
| Primary endpoint | Number of participants with treatment-emergent adverse events, serious adverse events, and any other dose-limiting toxicities as assessed by CTCAE v6.0. |
| Registry ID | NCT07798609 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:41.734Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07798609
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.